![Precision Pioneers EP 3: CEO of Faze Medicines, Phil Vickers on 'Running toward challenges' in precision medicine development | The Genetics Podcast | Podcasts on Audible | Audible.com Precision Pioneers EP 3: CEO of Faze Medicines, Phil Vickers on 'Running toward challenges' in precision medicine development | The Genetics Podcast | Podcasts on Audible | Audible.com](https://m.media-amazon.com/images/I/417U1byNuxS._SL500_.jpg)
Precision Pioneers EP 3: CEO of Faze Medicines, Phil Vickers on 'Running toward challenges' in precision medicine development | The Genetics Podcast | Podcasts on Audible | Audible.com
![New biotech backed by Third Rock launches with $81 million to go after ALS, other diseases - The Boston Globe New biotech backed by Third Rock launches with $81 million to go after ALS, other diseases - The Boston Globe](https://bostonglobe-prod.cdn.arcpublishing.com/resizer/qjA0NPz4ts9xfxSt-w2wCSHi-zY=/960x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/Y7NTSWXUMZFVFBGYJVVATIH3QQ.jpg)
New biotech backed by Third Rock launches with $81 million to go after ALS, other diseases - The Boston Globe
![Faze Medicines Appoints Biotech Leader Philip Vickers, Ph.D., as Chief Executive Officer | Business Wire Faze Medicines Appoints Biotech Leader Philip Vickers, Ph.D., as Chief Executive Officer | Business Wire](https://mms.businesswire.com/media/20210125005156/en/854062/22/Faze_logo_RGB_%281%29.jpg)